Mapping Catechol-O-Methyltransferase in vivo: Initial studies with [18F]RO41-0960
- 8 December 1995
- journal article
- Published by Elsevier in Life Sciences
- Vol. 58 (3) , 195-208
- https://doi.org/10.1016/0024-3205(95)02277-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Treatment of Parkinson's DiseaseNew England Journal of Medicine, 1993
- Extracellular Concentrations of Dopamine and Metabolites in the Rat Caudate After Oral Administration of a Novel Catechol‐O‐Methyltransferase Inhibitor Ro 40–7592Journal of Neurochemistry, 1992
- Different in vivo properties of three new inhibitors of catechol O‐methyltransferase in the ratBritish Journal of Pharmacology, 1992
- Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's DiseaseBasic & Clinical Pharmacology & Toxicology, 1990
- Mapping muscarinic receptors in human and baboon brain using [N‐11C‐methyl]‐benztropineSynapse, 1990
- Chapter 28 New Directions in Positron Emission Tomography-Part IIPublished by Elsevier ,1990
- Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity StudiesHelvetica Chimica Acta, 1989
- Mechanistic Positron Emission Tomography Studies: Demonstration of a Deuterium Isotope Effect in the Monoamine Oxidase‐Catalyzed Binding of [11C]l‐Deprenyl in Living Baboon BrainJournal of Neurochemistry, 1988
- Factors affecting the enzymatic formation of o-methylated dihydroxy derivativesBiochemical Pharmacology, 1965
- O-Methylation of Epinephrine and Other Catechols in vitro and in vivoScience, 1957